Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 1/20 | 0.55 |
| ▸ | ALDH1A3 | P47895 | 2/20 | 0.46 |
| ▸ | ACHE | P22303 | 6/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 6/20 | 0.44 |
| ▸ | BCHE | P06276 | 5/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.42 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.41 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.35 |
| ▸ | ABAT | P80404 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1338718 | 0.83 | LMNA (0.43) | ACHEPTGS2BCHELMNAMAPT | |
| SCHEMBL895976 | 0.82 | PTGS2 (0.62) | TYRALDH1A3ACHEPTGS2BCHE | |
| SCHEMBL1151204 | 0.81 | ALDH1A1 (0.42) | TYRACHEPTGS2BCHEALDH1A1 | |
| SCHEMBL6286470 | 0.79 | TYR (0.48) | TYRALDH1A3ACHEPTGS2BCHE | |
| SCHEMBL13527943 | 0.79 | ALDH1A1 (0.39) | TYRALDH1A3ALDH1A1LMNAMAPT | |
| Ethylene SCHEMBL6226363 | 0.78 | LMNA (0.48) | TYRALDH1A3ACHEPTGS2BCHE | |
| SCHEMBL2047680 | 0.78 | PTGS2 (0.53) | TYRALDH1A3ACHEPTGS2BCHE | |
| SCHEMBL9879225 | 0.78 | PTGS2 (0.56) | TYRALDH1A3ACHEPTGS2BCHE | |
| SCHEMBL18253207 | 0.77 | EPHX1 (0.44) | TYRACHEPTGS2BCHELMNA | |
| Cyclopropane SCHEMBL6228970 | 0.77 | LMNA (0.46) | TYRALDH1A3ACHEPTGS2BCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9901648-B2 | Stabilization of biomolecules using sugar polymers | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-02-27 | — | — | US | disclosed |
| US-9862709-B2 | Processes for making compounds useful as inhibitors of ATR kinase | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2018-01-09 | — | — | US | disclosed |
| US-20150274710-A1 | PROCESSES FOR MAKING COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE | VERTEX PHARMACEUTICALS INCORPORATED | 2015-10-01 | — | — | US | disclosed |
| US-9035053-B2 | Processes for making compounds useful as inhibitors of ATR kinase | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2015-05-19 | — | — | US | disclosed |
| US-20140377838-A1 | STABILIZATION OF BIOMOLECULES USING SUGAR POLYMERS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-12-25 | — | — | US | disclosed |
| US-8846686-B2 | Compounds useful as inhibitors of ATR kinase | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2014-09-30 | — | — | US | disclosed |
| US-20140155439-A1 | ENZYME INHIBITORS | CHROMA THERAPEUTICS LTD. (GB) | 2014-06-05 | — | — | US | disclosed |
| US-20130303576-A1 | ENZYME INHIBITORS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2013-11-14 | — | — | US | disclosed |
| US-20130184292-A1 | Processes for Making Compounds Useful as Inhibitors of ATR Kinase | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2013-07-18 | — | — | US | disclosed |
| US-20130089625-A1 | Compounds Useful as Inhibitors of ATR Kinase | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2013-04-11 | — | — | US | disclosed |
| US-20120149736-A1 | ENZYME INHIBITORS | CHROMA THERAPEUTICS LTD. (GB) | 2012-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130303576-A1 | ENZYME INHIBITORS | HDAC1, HDAC4, HDAC3 | TYR 2879/4885ALDH1A3 333/4885ACHE 810/4885 |
| US-20140155439-A1 | ENZYME INHIBITORS | HDAC4, HDAC1, HDAC3 | TYR 3071/4885ALDH1A3 634/4885ACHE 1156/4885 |
| US-20130184292-A1 | Processes for Making Compounds Useful as Inhibitors of ATR Kinase | ATR, ATRIP, CHEK1 | TYR 978/4885ALDH1A3 3642/4885ACHE 3228/4885 |
| US-20120149736-A1 | ENZYME INHIBITORS | HAT1, HDAC1, NAT1 | TYR 2093/4885ALDH1A3 185/4885ACHE 652/4885 |
| US-20140377838-A1 | STABILIZATION OF BIOMOLECULES USING SUGAR POLYMERS | TREH, HBG1, SMURF1 | TYR 2044/4885ALDH1A3 2695/4885ACHE 2768/4885 |
| US-20150274710-A1 | PROCESSES FOR MAKING COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE | ATR, ATRIP, CHEK1 | TYR 978/4885ALDH1A3 3642/4885ACHE 3228/4885 |
| US-20130089625-A1 | Compounds Useful as Inhibitors of ATR Kinase | ATR, CHEK1, MAP3K1 | TYR 1572/4885ALDH1A3 4469/4885ACHE 4362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.